(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.74%) $78.69
(2.52%) $2.20
(1.12%) $2 334.40
(3.70%) $27.68
(0.17%) $966.90
(-0.04%) $0.928
(-0.35%) $10.84
(-0.13%) $0.796
(-0.12%) $91.34
Live Chart Being Loaded With Signals
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally...
Stats | |
---|---|
本日の出来高 | 4.81M |
平均出来高 | 640 508 |
時価総額 | 423.92M |
EPS | £0 ( 2024-03-16 ) |
Last Dividend | £1.510 ( 2023-05-18 ) |
Next Dividend | £0 ( N/A ) |
P/E | 27.91 |
ATR14 | £0.487 (0.25%) |
ボリューム 相関
Advanced Medical 相関
10 最も正の相関 | |
---|---|
EJFI.L | 0.861 |
PSON.L | 0.855 |
VSL.L | 0.845 |
ALL.L | 0.841 |
NAIT.L | 0.84 |
WIN.L | 0.837 |
MIG.L | 0.836 |
BEZ.L | 0.836 |
LXI.L | 0.834 |
DHSD.L | 0.833 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Advanced Medical 相関 - 通貨/商品
Advanced Medical 財務諸表
Annual | 2023 |
収益: | £126.21M |
総利益: | £63.73M (50.49 %) |
EPS: | £0.0736 |
FY | 2023 |
収益: | £126.21M |
総利益: | £63.73M (50.49 %) |
EPS: | £0.0736 |
FY | 2022 |
収益: | £124.33M |
総利益: | £68.62M (55.19 %) |
EPS: | £0.0942 |
FY | 2021 |
収益: | £108.60M |
総利益: | £61.07M (56.23 %) |
EPS: | £0.0813 |
Financial Reports:
No articles found.
Advanced Medical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0.640 (N/A) |
£0 (N/A) |
£0 (N/A) |
£1.510 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £0.380 | 2011-05-11 |
Last Dividend | £1.510 | 2023-05-18 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 26 | -- |
Total Paid Out | £14.14 | -- |
Avg. Dividend % Per Year | 0.41% | -- |
Score | 4.13 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.64 | |
Div. Directional Score | 9.02 | -- |
Year | Amount | Yield |
---|---|---|
2011 | £0.525 | 0.72% |
2012 | £0.475 | 0.51% |
2013 | £0.540 | 0.85% |
2014 | £0.630 | 0.57% |
2015 | £0.730 | 0.58% |
2016 | £0.850 | 0.48% |
2017 | £0.970 | 0.44% |
2018 | £1.170 | 0.38% |
2019 | £1.400 | 0.51% |
2020 | £1.550 | 0.53% |
2021 | £1.780 | 0.73% |
2022 | £2.01 | 0.61% |
2023 | £1.510 | 0.57% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
S32.L | Dividend Junior | 2023-09-14 | Semi-Annually | 9 | 1.97% | |
HLMA.L | Dividend Knight | 2023-07-13 | Semi-Annually | 32 | 0.43% | |
BAKK.L | Dividend Knight | 2023-09-14 | Annually | 7 | 4.28% | |
W7L.L | Dividend Knight | 2023-11-09 | Annually | 8 | 2.69% | |
MTVW.L | Dividend Knight | 2023-07-06 | Semi-Annually | 32 | 2.55% | |
DRX.L | Dividend Knight | 2023-08-24 | Semi-Annually | 19 | 2.48% | |
SMS.L | Dividend Knight | 2023-07-06 | Quarterly | 13 | 2.02% | |
ING.L | Dividend Knight | 2023-09-21 | Annually | 32 | 2.29% | |
BPCR.L | Dividend Knight | 2023-08-17 | Quarterly | 8 | 1.46% | |
PAF.L | Ex Dividend Knight | 2023-11-30 | Annually | 16 | 1.80% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.126 | 1.500 | 7.48 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0549 | 1.200 | 8.17 | 9.80 | [0 - 0.3] |
returnOnEquityTTM | 0.0653 | 1.500 | -0.386 | -0.579 | [0.1 - 1] |
payoutRatioTTM | 0.301 | -1.000 | 6.99 | -6.99 | [0 - 1] |
currentRatioTTM | 5.67 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.00 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.79 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0316 | -1.500 | 9.47 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.88 | 1.000 | 6.71 | 6.71 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0662 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0211 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0374 | -1.500 | 9.85 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.505 | 1.000 | 4.92 | 4.92 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.142 | 1.000 | 9.16 | 9.16 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.582 | 1.000 | 2.32 | 2.32 | [0.2 - 2] |
assetTurnoverTTM | 0.436 | 0.800 | -0.424 | -0.339 | [0.5 - 2] |
Total Score | 11.40 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.85 | 1.000 | 7.39 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0653 | 2.50 | -0.248 | -0.579 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0211 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.131 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0662 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.301 | 1.500 | 6.99 | -6.99 | [0 - 1] |
pegRatioTTM | 59.02 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.115 | 1.000 | 9.64 | 0 | [0.1 - 0.5] |
Total Score | 6.64 |
Advanced Medical
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。